With the amassed value of the company based on its existing stock price alongside the total amount of outstanding ... which is virtually never the case. NASDAQ:UTHR has an EPS value of 15.17 with an EPS growth this year at 19.90%. …
Big-cap biotech United Therapeutics (UTHR) disappointed investors for the second quarter in a row Tuesday, as it missed Q2 estimates and its new drug launch continued to underwhelm. The stock hit a five-month low in early trading on the …
Six equities research analysts have rated the stock with a sell rating ... Association holds 0.04% of its portfolio in United Therapeutics Corporation (NASDAQ:UTHR) for 81,833 shares. Since February 16, 2017, it had 0 insider purchases, …
The stock has "Buy" rating by Piper Jaffray on Friday ... Ltd Limited Liability Company has invested 0.64% in United Therapeutics Corporation (NASDAQ:UTHR). Mcrae Cap reported 21,400 shares. Stephens Inv Management Grp Ltd …
Today's Most Active Call & Put Options of the S&P 500 » United Therapeutics Corp (UTHR) options are showing a volume of 5,328 contracts thus far today. That number of contracts represents approximately 532,800 underlying shares, …
United Therapeutics Corporation (Nasdaq:UTHR) hit a new 52-week low Tuesday as it is currently trading at $36.75, below its previous 52-week low of $36.80 with one million shares traded as of 3:06 p.m. ET. Average volume has been 1.5 …
Most Attractive Large Cap stock United Therapeutics (UTHR) gained 10% and Most Attractive Small ... The successes of the Most Attractive and Most Dangerous stocks highlight the value of our forensic accounting. Being a true value …
If you want a Stock Review on PRGO, IMNP, TNXP or UTHR then come over to http://dailystocktracker.com/register/ …
In this call, Johnson allegedly learned of the successful completion of a trial for the company's drug Viveta (later renamed Tyvaso), and purchased 10,000 shares of UTHR stock in his wife's brokerage account on October 31, 2007. The SEC …
On the other hand, when a company regularly misses Street expectations, the stock is often punished. According to the latest available information United Therapeutics Corporation (NASDAQ:UTHR) is expected to issue its next …